SpudCells and Glioblastoma: The Era of Programmable Biology Begins

The public unveiling of SpudCells and the preclinical triumph of GPNMB-targeted CAR-T cells mark a systemic shift from passive observation to active, programmable cellular engineering. This dual breakthrough dismantles the historical barriers of tumor microenvironment resistance and redefines the very nature of life, offering a future where biological systems are engineered, predicted, and optimized with unprecedented precision.